Trends in antimicrobial resistance among clinical isolates of the Bacteroides fragilis group from 1992 to 1997 in Montreal, Canada

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 10, 1999, Pages 2517-2519

  Labbé, Annie Claude ^a   Bourgault, Anne Marie ^a   Vincelette, Jean ^a   Turgeon, Pierre L ^a   Lamothe, François ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFOXITIN; CLINDAMYCIN; IMIPENEM; METRONIDAZOLE; PENICILLIN G; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; TIMENTIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BACTEROIDES; BACTEROIDES CACCAE; BACTEROIDES DISTASONIS; BACTEROIDES EGGERTHII; BACTEROIDES FRAGILIS; BACTEROIDES OVATUS; BACTEROIDES STERCORIS; BACTEROIDES THETAIOTAOMICRON; BACTEROIDES UNIFORMIS; BACTEROIDES VULGATUS; CANADA; CONTROLLED STUDY; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE;

EID: 0032870121     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.10.2517     Document Type: Article

References (13)

1. Bianchini, H., L. B. Fernandez Canigia, C. Bantar, and J. Smavevskj. 1997. Trends in antimicrobial resistance of the Bacteroides fragilis group: a 20-year study at a medical center in Buenos Aires, Argentina. Clin. Infect. Dis. 25:5268-5269.
2. Bourgault, A.-M., G. K. Harding, J. A. Smith, G. B. Horsman, T. J. Marrie, and F. Lamothe. 1986. Survey of anaerobic susceptibility patterns in Canada. Antimicrob. Agents Chemother. 30:798-801.
3. Bourgault, A.-M., F. Lamothe, and D. J. Hoban. 1992. Survey of Bacteroides fragilis group susceptibility patterns in Canada. Antimicrob. Agents Chemother. 36:343-347.
4. Dalmau, D., M. Cayouette, F. Lamothe, J. Vincelelte, N. Lachante, A.-M. Bourgault, C. Gaudreau, and P. L. Turgeon. 1997. Clindamycin resistance in the Bacteroides fragilis group: association with hospital-acquired infections. Clin. Infect. Dis. 24:874-877.
5. Finegold, S. M., and H. M. Wexler. 1996. Present status of therapy for anaerobic infections. Clin. Infect. Dis. 23:S9-S14.
6. Garcia-Rodriguez, J. E., and J. E. Garcia-Sanchez. 1990. Evolution of antimicrobial susceptibility in isolates of the Bacteroides fragilis group in Spain. Clin. Infect. Dis. 12:S142-S151.
7. Lee, K., Y. Chuong, S. H. Jeong, X.-S. Xu, and O. H. Kwon. 1996. Emerging resistance of anaerobic bacteria to antimicrobial agents in South Korea. Clin. Infect. Dis. 23:S73-S77.
8. National Committee for Clinical Laboratory Standards. 1993. Methods for antimicrobial susceptibility testing of anaerobic bacteria. Approved standard, 3rd ed. NCCLS document M11-A3. National Committee for Clinical Laboratory Standards, Wayne, Pa.
9. National Committee for Clinical Laboratory Standards. 1997. Methods for antimicrobial susceptibility testing of anaerobic bacteria. Approved standard, 4th ed. NCCLS document M11-A4. National Committee for Clinical Laboratory Standards, Wayne, Pa.
10. Rasmussen, B. A., K. Bush, and F. P. Tally. 1997. Antimicrobial resistance in anaerobes. Clin. Infect. Dis. 24:S110-S120.
11. Snydman, D. R., L. McDermott, G. J. Cuchural, D. W. Hecht, P. B. Ianni, L. J. Harrell, S. G. Jenkins, J. P. O'Keefe, C. L. Pierson, J. D. Rihs, V. L. Yu, S. M. Finegold, and S. L. Gorbach. 1996. Analysis of trends in antimicrobial resistance patterns among clinical isolates of Bacteroides fragilis group species from 1990 to 1994. Clin. Infect. Dis. 23:S54-S65.
12. Summanen, P., E. J. Baron, D. M. Citron, C. A. Strong, H. M. Wexler, and S. M. Finegold. 1993. Wadsworth anaerobic bacteriology manual, 5th ed. Star Publishing, Belmont, Calif.
13. Turgeon, P., V. Turgeon, M. Gourdeau, J. Dubois, and F. Lamothe. 1994. Longitudinal study of susceptibilities of species of the Bacteroides fragilis group to five antimicrobial agents in three medical centers. Antimicrob. Agents Chemother. 38:2276-2279.